Quality Management System (QMS): How Clinix QM Works
By Dr Youssef Ghaly and Dr Mostafa Helmy · Published July 2025
Abstract
In clinical AI, output quality is a patient safety issue, and this paper presents Clinix QM — the systematic framework intended to ensure every ClinixSummary output meets clinical documentation standards. It describes the processes, metrics, and governance structures that constitute Clinix QM, aimed at quality officers, clinical leaders, and compliance teams evaluating ClinixSummary for deployment. The paper concludes that quality management in clinical AI requires the same rigour applied to medical devices and pharmaceuticals, and that Clinix QM makes that commitment operational, measurable, and governed.
What the paper covers
A four-pillar QMS framework
Clinix QM operates across four pillars: Proactive Quality (error prevention through model design, training methodology, and output validation rules), Reactive Quality (error detection via clinician feedback, automated monitoring, and manual QA review), Continuous Improvement (the Kai-zen loop), and Governance (oversight structures, documentation, and accountability).
Model validation gates before deployment
Every model update must pass automated regression testing against a curated suite of 10,000+ clinical scenarios, specialty-specific accuracy benchmarks that must meet or exceed the previous model version, clinical review by specialty advisors for changes affecting clinical reasoning or terminology, and A/B testing on a subset of production traffic before full rollout.
Output validation rules on every note
Generated notes pass through a rule engine that flags potential issues before the clinician sees the output — missing mandatory sections, medication dosages outside normal ranges, contradictory clinical findings, and incomplete procedure documentation — with flagged items highlighted for clinician review.
Three reactive quality channels
Every clinician edit, correction, or rating is captured, categorised (e.g. terminology error, section misclassification, missing information), and prioritised for remediation; a dedicated clinical QA team of licensed clinicians conducts manual reviews stratified by specialty, note type, and complexity; and production outputs are continuously monitored for statistical anomalies that trigger automated alerts.
The Kai-zen loop and tracked metrics
Findings from all three reactive channels are aggregated weekly into a prioritised improvement backlog addressed in the next model update cycle. Tracked metrics include Clinician Acceptance Rate (target: >95% by end of 2025), Clinical Accuracy Score per specialty, mean edits per note (trending toward zero), critical error rate for medication, allergy, and procedure errors (target: <0.1%), and time from error detection to model fix deployment.
Governance and controlled documentation
Clinix QM is governed by a Quality Steering Committee — the Chief Medical Officer, Head of AI, Head of Quality, and external clinical advisors — which meets monthly to review metrics, approve model releases, and set quality targets. All QMS processes live in a controlled document system with version tracking and approval workflows, available for review by customers and regulators upon request.
Figures and statements reflect the paper as published in July 2025.